Ms. Nicole Crenshaw reports

MEDMIRA INC. AND LOVELL ANNOUNCE PARTNERSHIP TO INCREASE ACCESS TO REVEAL G4 HIV-1/2 RAPID TEST FOR VA, DEPARTMENT OF DEFENSE

Medmira Inc. and Lovell Government Services have partnered to serve federal health care systems such as the Veterans Health Administration (VHA), the Military Health System (MHS) and the Indian Health Service (IHS). Lovell Government Services will serve as Medmira's service-disabled veteran-owned small business (SDVOSB) vendor to serve these customers through federal contracting systems.

The Reveal G4 HIV-1/2 antibody rapid test (Reveal G4 HIV) is the world's fastest HIV rapid test. Based on Medmira's patented rapid vertical flow technology, the Reveal G4 HIV offers a simple testing solution with immediate results that do not fade away. Therefore, offering the best rapid testing solution which is FDA (U.S. Food and Drug Administration) approved since 2004. The Reveal G4 HIV is offered in three convenient formats (point-of-care finger-stick whole blood, laboratory-format serum/plasma and venipuncture whole blood) to accommodate any health care setting without the need for timing devices. With its unique built-in procedural and reagent control line, an operator can be assured that each test has been performed correctly.

A unique feature of Medmira's patented technology is the elimination of the pro-zone (hook) effect, a known common issue in traditional serological tests, where a high concentration of antibodies can lead to false-negative results. Medmira's technology avoids this by ensuring antibody binding occurs in a controlled, localized environment while excess antibodies are washed away. The result is a highly accurate test that maintains reliability across a wide range of antibody levels.

As Medmira's SDVOSB vendor, Lovell is excited to bring this product to federal health care providers. Medmira is now available through the Department of Veterans Affairs' Federal Supply Schedule (FSS), GSA Advantage, the Defense Logistics Agency's Electronic Catalog (ECAT), and the Department of Defense's Distribution and Pricing Agreement (DAPA). Listing products on contract vehicles with Lovell streamlines the acquisition process while helping government agencies meet their SDVOSB procurement goals.

"We're proud to partner with Medmira to bring an advanced rapid testing solution to federal health care providers. The speed and reliability of their Reveal G4 platform supports clinicians in making timely decisions and improves the care experience for our veterans," said Chris Lovell, Major, USMC (retired), chief executive officer of Lovell Government Services.

"Medmira is proud to partner with Lovell Government Services, SDVOSB, to support federal procurement needs through their eCAT, GSA, and VA FSS contract vehicles," said Nicole Crenshaw, vice-president of commercial operations at Medmira. "This strategic partnership provides us with the critical reach into key government markets, enabling greater access to our innovative diagnostic solutions where they're needed most."

About Medmira Inc.

Medmira is the developer and owner of rapid vertical flow technology. The company's rapid test applications built on RVF technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as HIV and hepatitis C in just three easy steps. The company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. Medmira's HIV rapid test has been the first approved in Canada and the second HIV rapid test approved in the United States.

We seek Safe Harbor.